From the Antipodes to the Motherland: Reflections on HTA Decision Makers as Budget Takers and Budget Makers

OHE Lunchtime Seminar with OHE's Deputy Director Paul Lorgelly

On Monday 14th December, OHE’s Deputy Director Paula Lorgelly will lead an OHE Lunchtime Seminar on the topic of: HTA decision makers as budget takers and budget makers.

The seminar will highlight that decision-making criteria employed by health technology assessment (HTA) agencies differs between countries. Specifically, while the National Institute for Health and Care Excellence (NICE), the Australian Pharmaceutical Benefits Advisory Committee (PBAC) and the New Zealand Pharmaceutical Management Agency (PHARMAC) may seem similar, in one respect – assessing affordability – they are very different. 

Using a number of case studies, including sofosbuvir for Hepatitis C, the decisions and deliberations of each agency and its Health Ministry will be compared.  Additionally, there will also be a discussion of the UK’s Cancer Drug Fund, which exceeded its budget by 50%. 

The presentation will conclude with a discussion of possible economic theories that may underpin improvements in approaches to HTA at NICE, PBAC and PHARMAC in the future.  



Monday, 14 December 2015